Biological Systems: Open Access

ISSN - 2329-6577

44-7723-59-8358

Genotoxicity of gemcitabine low dose in white rat bone marrow cells

JOINT EVENT on 2nd International Conference on Bioscience and 5th International Conference on Integrative Biology

June 19-21, 2017 London, UK

Abdul Rahman A I Alyahya

Shaqra University, Saudi Arabia

: Biol Syst Open Access

Abstract :

Gemcitabine is a modern chemical drug used widely against many serious diseases including advanced cancers such as lung cancer, bladder and ovarian cancers and several blood cancers. Gemcitabine is one of the preferred choices in the treatment of pancreatic cancer. A short-term test was conducted and the drug showed rapid and strong ability to detect toxicity or distorting the material studied in the neighborhood cells. Results showed that there are some changes in cell parameters which can be determined by cellular examination accurately. Exposing male inbred line SWR/J of laboratory mice to low dose of the gemcitabine drug (125 mg/ kg) individually and in combination, affected significantly in different time intervals, mitotic divisions, chromosomal aberrations and abnormalities. The severity of abnormalities was increased with the passage of treated time.

Biography :

Email: alya7ya@su.edu.sa

Top